单味活血化瘀药治疗骨质疏松症的研究进展  

Research progress of treating Osteoporosis with single Chinese medicine of activating blood and dissolving stasis

作　　者：康轶鑫 于善江[2] 于有建[3] 

机构地区：[1]山东省淄博市临淄区人民医院推拿科,255400 [2]山东省淄博市临淄区人民医院风湿科,255400 [3]山东省淄博市临淄区人民医院儿科,255400

出　　处：《国际中医中药杂志》2010年第3期267-270,共4页International Journal of Traditional Chinese Medicine

基　　金：淄博市科学技术发展计划项目（项目编号：2010GG034）

摘　　要：近年来的中药药理学研究发现，活血化瘀药中的骨碎补、牛膝、丹参和三七有抗骨质疏松作用，能提高骨矿密度和骨矿总量，促进骨形成，减少骨吸收。兹将国内外近年来的研究现状进行了整理分析，以期为骨质疏松症的防治提供用药思路与方法。In recent years, pharmacological researches of Chinese medicine found that the single Chinese medicines of activating blood and dissolving stasis, such as Drynaria and Bidentata and Salvia and Panax notoginseng had very good effects of resisting osteoporosis, significantly improving bone mineral density （BMD）and bone mineral content （BMC）, promoting bone formation, and preventing bone absorption. Based on the documentations from home and abroad, the overview had analyzed the current situation for providing new ideas and methods of osteoporosis prevention and treatment.

关 键 词：骨质疏松症 活血化瘀药 研究进展 

分 类 号：R259[医药卫生—中西医结合]